20413731

Source:http://linkedlifedata.com/resource/pubmed/id/20413731

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0022116, umls-concept:C0026809, umls-concept:C0027055, umls-concept:C0033684, umls-concept:C0205171, umls-concept:C1292733
pubmed:issue	7
pubmed:dateCreated	2010-6-17
pubmed:abstractText	Evasins (chemokine-binding proteins) have been shown to selectively neutralize chemokine bioactivity. We investigated the potential benefits of Evasin-3 on mouse myocardial ischemia/reperfusion injury.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9505803
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CXCR, http://linkedlifedata.com/resource/pubmed/chemical/Troponin I
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1524-4636
pubmed:author	pubmed-author:BraunersreutherVincentV, pubmed-author:DeruazMaudM, pubmed-author:LengletSébastienS, pubmed-author:LerchRenéR, pubmed-author:MachFrançoisF, pubmed-author:MontecuccoFabrizioF, pubmed-author:MontessuitChristopheC, pubmed-author:PelliGrazianoG, pubmed-author:PellieuxCorinneC, pubmed-author:ProudfootAmanda EAE
pubmed:issnType	Electronic
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1371-7
pubmed:meshHeading	pubmed-meshheading:20413731-Animals, pubmed-meshheading:20413731-Anti-Inflammatory Agents, pubmed-meshheading:20413731-Biological Markers, pubmed-meshheading:20413731-Blotting, Western, pubmed-meshheading:20413731-Chemotaxis, Leukocyte, pubmed-meshheading:20413731-Disease Models, Animal, pubmed-meshheading:20413731-Dose-Response Relationship, Drug, pubmed-meshheading:20413731-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:20413731-Immunohistochemistry, pubmed-meshheading:20413731-Injections, Intraperitoneal, pubmed-meshheading:20413731-Male, pubmed-meshheading:20413731-Mice, pubmed-meshheading:20413731-Mice, Inbred C57BL, pubmed-meshheading:20413731-Myocardial Infarction, pubmed-meshheading:20413731-Myocardial Ischemia, pubmed-meshheading:20413731-Myocardial Reperfusion Injury, pubmed-meshheading:20413731-Myocardium, pubmed-meshheading:20413731-Neutrophil Infiltration, pubmed-meshheading:20413731-Oxidative Stress, pubmed-meshheading:20413731-Perfusion, pubmed-meshheading:20413731-Phosphorylation, pubmed-meshheading:20413731-Receptors, CXCR, pubmed-meshheading:20413731-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20413731-Signal Transduction, pubmed-meshheading:20413731-Troponin I
pubmed:year	2010
pubmed:articleTitle	Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
pubmed:affiliation	Cardiology Division, Department of Medicine, Geneva University Hospital, Foundation for Medical Researches, 64 Avenue Roseraie, 1211 Geneva, Switzerland. fabrizio.montecucco@unige.ch
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't